Associated Papers
APF2: an improved ensemble method for pharmacogenomic variant effect prediction.
Zhou Y et al.
The Pharmacogenomics Journal, 2024
38802404 (PubMed )
Supplement: 41397_2024_338_MOESM2_ESM.xlsx › Sheet1
Functional Characterization of Allelic Variations of Human Cytochrome P450 2C8 (V181I, I244V, I331T, and L361F).
Lee YB et al.
International Journal of Molecular Sciences, 2023
Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles.
Chamboko CR et al.
International Journal of Molecular Sciences, 2023
36834793 (PubMed )
Supplement: ijms-24-03383-s001.zip › ijms-2130595-supplementary.pdf
Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro.
Zou LL et al.
Frontiers in Pharmacology, 2023
Analysis of CYP2J2 mutations in the Chinese Uyghur population.
Li H et al.
American Journal of Translational Research, 2021
Germline Mutation in MUS81 Resulting in Impaired Protein Stability is Associated with Familial Breast and Thyroid Cancer.
Pinheiro M et al.
Cancers, 2020
32443704 (PubMed )
Supplement: cancers-12-01289-s001.zip › cancers-768495_-Supplementary_Tables_.xlsx › Table_S2
An optimized prediction framework to assess the functional impact of pharmacogenetic variants.
Zhou Y et al.
The Pharmacogenomics Journal, 2019
30206299 (PubMed )
Supplement: 41397_2018_44_MOESM5_ESM.xlsx › Sheet1
Genetic polymorphisms of the drug-metabolizing enzyme CYP2J2 in a Tibetan population.
Cao P et al.
Medicine, 2018
Terfenadine metabolism of human cytochrome P450 2J2 containing genetic variations (G312R, P351L and P115L).
Jeong D et al.
Drug Metabolism and Pharmacokinetics, 2018
Evidence for association of polymorphisms in CYP2J2 and susceptibility to essential hypertension.
Wu SN et al.
Annals of Human Genetics, 2007
CYP2J2*7 single nucleotide polymorphism in a Chinese population.
Wang H et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2006
Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity.
Lee SS et al.
Pharmacogenetics and Genomics, 2005
Genetic polymorphisms, drug metabolism and drug concentrations.
Shenfield GM
The Clinical Biochemist. Reviews, 2004
Select a paper to view details